Cargando…

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

Objective: To determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels after the first dose of vaccine can predict the final antibody response, and whether this is dependent on the vaccine type. Methods: Sixty-nine recipients of BNT162b2 (Pfizer/BioNTech) and 55...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perkmann, Thomas, Perkmann-Nagele, Nicole, Mucher, Patrick, Radakovics, Astrid, Repl, Manuela, Koller, Thomas, Jordakieva, Galateja, Wagner, Oswald F., Binder, Christoph J., Haslacher, Helmuth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317449/ https://www.ncbi.nlm.nih.gov/pubmed/34332084 http://dx.doi.org/10.1016/j.ijid.2021.07.063

Ejemplares similares

Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
por: Perkmann, Thomas, et al.
Publicado: (2021)

The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
por: Perkmann, Thomas, et al.
Publicado: (2022)

Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology
por: Perkmann, Thomas, et al.
Publicado: (2023)

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
por: Perkmann, Thomas, et al.
Publicado: (2021)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
por: Perkmann, Thomas, et al.
Publicado: (2023)

SARS-CoV-2 Infections in “less visible” Hospital Staff: The Roles and Safety of Environmental Services and Allied Health Professionals
por: Jensen, Sebastian, et al.
Publicado: (2023)

Basal myokine levels are associated with quality of life and depressed mood in older adults
por: Mucher, Patrick, et al.
Publicado: (2021)

Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222
por: Terpos, Evangelos, et al.
Publicado: (2022)

A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222
por: Nantanee, Rapisa, et al.
Publicado: (2022)

Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
por: Suah, Jing Lian, et al.
Publicado: (2022)

A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen
por: Baek, Yae Jee, et al.
Publicado: (2023)

Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank
por: Haslacher, Helmuth, et al.
Publicado: (2018)

Midday and nadir salivary cortisol appear superior to cortisol awakening response in burnout assessment and monitoring
por: Pilger, Alexander, et al.
Publicado: (2018)

First-generation BNT162b2 and AZD1222 vaccines protect from COVID-19 pneumonia during the Omicron variant emergence
por: Murillo-Zamora, E., et al.
Publicado: (2022)

Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
por: Müller, Michael, et al.
Publicado: (2022)

Adverse Events Associated with BNT162b2 and AZD1222 Vaccines in the Real World: Surveillance Report in a Single Italian Vaccine Center
por: Costantino, Maria, et al.
Publicado: (2022)

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries
por: Dag Berild, Jacob, et al.
Publicado: (2022)

The usefulness of CYFRA 21–1 to diagnose and predict preeclampsia: a nested case-control study
por: Kuessel, Lorenz, et al.
Publicado: (2016)

AZD-1222: Guillain-Barre syndrome
Publicado: (2021)

AZD-1222: Rhabdomyolysis: case report
Publicado: (2022)

AZD-1222: Polyarthralgia: case report
Publicado: (2021)

Azd-1222: Myelitis: case report
Publicado: (2022)

Azd-1222: Thrombocytopenia: case report
Publicado: (2022)

Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
por: Szabó, Enikő, et al.
Publicado: (2023)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2
por: Müller-Hilke, Brigitte, et al.
Publicado: (2022)

Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
por: Tabatabaeifar, Sorosh, et al.
Publicado: (2023)

Evaluation of the Septifast M(Grade) Test on Standard Care Wards—A Cohort Study
por: Ratzinger, Franz, et al.
Publicado: (2016)

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
por: Abdullahi, Adam, et al.
Publicado: (2022)

ISG12 is a critical modulator of innate immune responses in murine models of sepsis()
por: Uhrin, P., et al.
Publicado: (2013)

AZD-1222: Nephrotic syndrome: case report
Publicado: (2021)

AZD-1222: Lack of efficacy: case report
Publicado: (2022)

AZD-1222: Immune thrombocytopenia: case report
Publicado: (2022)

AZD-1222: Leukocytoclastic vasculitis: case report
Publicado: (2022)

AZD-1222: Neck lymphadenitis: case report
Publicado: (2022)

AZD-1222: Immune thrombocytopenia: case report
Publicado: (2022)

Azd-1222: Immune thrombocytopaenia: case report
Publicado: (2022)

Azd-1222: Autoimmune encephalitis: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6m24df9r1qg0j3f5l9gv8et9sb